AACR/X
Apr 28, 2025, 13:23
PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage solid cancers – AACR
AACR shared a post on X:
“PD-1 immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers, according to results presented by Andrea Cercek.”
More posts featuring AACR.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 9, 2025, 16:49
Jun 9, 2025, 16:39
Jun 9, 2025, 16:25
Jun 9, 2025, 16:15
Jun 9, 2025, 15:51
Jun 9, 2025, 15:34
Jun 9, 2025, 15:08
Jun 9, 2025, 14:50